Skip to main content
. 2016 Apr 29;17:224. doi: 10.1186/s13063-016-1321-5

Table 3.

Schedule of assessments

Measures Enrollment Baseline 6 weeks 12 weeks 24 weeks
Screening and enrollment
  Eligibility screening
  Informed consent
Baseline information
  Sociodemographics*
  Expectations and preference
  Back pain history and comorbidities
Primary outcomes
  Low back pain intensity (DVPRS)
  Back-related function (RMDQ)
Secondary outcomes
  Pain medication use
  PTSD CheckList—Civilian version (PCL-C)
  Health-related quality of life (SF-12)
  Satisfaction with treatment
  Global improvement
Cost-effectiveness outcomes
  Work productivity
  Medical utilization and cost
Exploratory outcomes
  PROMIS-29 and pain interference
  Depression (PHQ-9) and anxiety (GAD-7)
  Relationship satisfaction (DAS)
  Pain self-efficacy (PSEQ)
  Sleep quality (PSQI)
  Coping strategies (CSQ)
  Post-concussive symptoms (NSI)
Possible covariates and confounders
  Exercise history
  Low back pain treatments
  Alcohol, drugs, and smoking

*Sociodemographic information includes gender, age, relationship status, ethnicity, race, income, housing, education level, and military service history

DVPRS = Defense and Veterans Pain Rating Scale; RMDQ = Roland Morris Disability Questionnaire; PROMIS = Patient Reported Outcome Measurement Information System; SF-12 = Short Form 12-item Health Survey; PHQ-9 = 9-item Patient Health Questionnaire; GAD-7 = 7-item General Anxiety Disorder survey; DAS = Dyadic Adjustment Scale; PSQI = Pittsburgh Sleep Quality Index; NSI = Neurobehavioral Symptom Inventory